Patents by Inventor Steven B. Kanner

Steven B. Kanner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polynucleotides encoding human SLAP-2:a novel SH2/SH3 domain-containing human SLAP homologue having immune cell-specific expression
    Patent number: 7101686
    Abstract: The present invention describes a newly discovered full-length polynucleotide encoding an SH2/SH3 domain-containing adapter protein, called hSLAP-2, cloned, isolated and identified. Also described are the hSLAP-2 polypeptide sequence, expression vectors, host cells, agonists, antagonists, anti-sense molecules, and antibodies related to the polynucleotide and/or polypeptide of the present invention. Methods for screening for modulators, particularly inhibitors, of the hSLAP-2 protein and use of the hSLAP-2 polynucleotide and polypeptide for therapeutics and diagnostics are described.
    Type: Grant
    Filed: November 20, 2001
    Date of Patent: September 5, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Han Chang, Wen-Pin Yang, Yuli Wu, Gena S. Whitney, Juan J. Perez-villar, Steven B. Kanner
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Patent number: 7037926
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: May 2, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Joel C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M. P. Doweyko, Joseph A. Furch, III
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Patent number: 6958336
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: October 25, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Joel C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M. P. Doweyko, Joseph A. Furch, III
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Patent number: 6956045
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: October 18, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Joel C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M. P. Doweyko, Joseph A. Furch, III
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Patent number: 6953795
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: October 11, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Joel C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M. P. Doweyko, Joseph A. Furch III
  • Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
    Publication number: 20040214212
    Abstract: A novel gene 254P1D6B and its encoded protein, and variants thereof, are described wherein 254P1D6B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 254P1D6B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 254P1D6B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 254P1D6B can be used in active or passive immunization.
    Type: Application
    Filed: January 23, 2004
    Publication date: October 28, 2004
    Inventors: Arthur B. Raitano, Aya Jakobovits, Pia M. Challita-Eid, Wangmao Ge, Juan J. Perez-Villar, Steven B. Kanner
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Publication number: 20040110752
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Application
    Filed: August 15, 2003
    Publication date: June 10, 2004
    Inventors: Joel C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M.P. Doweyko, Joseph A. Furch
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Publication number: 20040077695
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Application
    Filed: August 15, 2003
    Publication date: April 22, 2004
    Inventors: Jo I C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M. P. Doweyko, Joseph A. Furch
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Publication number: 20040067990
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Application
    Filed: August 15, 2003
    Publication date: April 8, 2004
    Inventors: Joel C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M. P. Doweyko, Joseph A. Furch
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Publication number: 20040067989
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Application
    Filed: August 15, 2003
    Publication date: April 8, 2004
    Inventors: Joel C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M. P. Doweyko, Joseph A. Furch
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Patent number: 6706717
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: March 16, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: Joel C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M. P. Doweyko, Joseph A. Furch, III
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Publication number: 20030069238
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Application
    Filed: December 20, 2001
    Publication date: April 10, 2003
    Inventors: Joel C. Barrish, Jagabandhu Das, Steven B. Kanner, Chunjian Liu, Steven H. Spergel, John Wityak, Arthur M. P. Doweyko, Joseph A. Furch
  • Identification and cloning of a full-length human Clnk-related gene, MIST (Mast Cell Immunoreceptor Signal Transducer)
    Publication number: 20020155563
    Abstract: The present invention describes a newly discovered full-length polynucleotide encoding an SH2 domain-containing adapter protein, called human MIST, cloned, isolated and identified from a human spleen cDNA library. Also described are the MIST polypeptide sequence, expression vectors, host cells, agonists, antagonists, antisense molecules, and antibodies related to the polynucleotide and/or polypeptide of the present invention. Novel splice variant forms of human MIST are provided. Methods for screening for modulators, particularly inhibitors, of the MIST protein and use of the human MIST polynucleotide and polypeptide for therapeutics and diagnostics are described.
    Type: Application
    Filed: September 28, 2001
    Publication date: October 24, 2002
    Inventors: Juan J. Perez-Villar, Han Chang, Wen-Pin Yang, Yuli Wu, Gena S. Whitney, Steven B. Kanner